+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Catastrophic Antiphospholipid Syndrome Presenting as Congestive Heart Failure in a Patient with Thrombotic Microangiopathy

Catastrophic Antiphospholipid Syndrome Presenting as Congestive Heart Failure in a Patient with Thrombotic Microangiopathy

Texas Heart Institute Journal 46(1): 48-52

Thrombotic microangiopathic syndromes are characterized by thrombus formation leading to microangiopathic hemolytic anemia, thrombocytopenia, and end-organ injury that most often affects the kidney and brain. Patients with thrombotic microangiopathy can also present with cardiac involvement, which has been shown to worsen their prognosis. We describe the case of a 46-year-old woman who presented with acute congestive heart failure as a manifestation of catastrophic antiphospholipid syndrome, which is characterized by rapidly progressing multiorgan involvement. Targeted therapy improved our patient's cardiomyopathy and saved her life. Increased recognition of thrombotic microangiopathy as an underlying pathophysiologic mechanism in heart failure and initiation of timely treatment may help to prevent death in patients with thrombotic microangiopathy.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 066556817

Download citation: RISBibTeXText

PMID: 30833839

Related references

Catastrophic antiphospholipid syndrome presenting with renal thrombotic microangiopathy and diffuse proliferative glomerulonephritis. Clinical and Experimental Rheumatology 24(1): 110, 2006

Catastrophic antiphospholipid antibody syndrome in a child with thrombotic microangiopathy. Indian Journal of Nephrology 22(4): 310-313, 2012

Thrombotic microangiopathy with liver, gut, and bone infarction (catastrophic antiphospholipid syndrome) associated with HELLP syndrome. Clinical Rheumatology 24(2): 166-168, 2005

Catastrophic antiphospholipid syndrome with severe acute thrombotic microangiopathy and hemorrhagic complications. Case Reports in Medicine 2013: 915309, 2013

A 3-year follow-up of a patient with acute renal failure caused by thrombotic microangiopathy related to antiphospholipid syndrome: case report. Lupus 26(7): 777-782, 2017

Severe limb necrosis: primary thrombotic microangiopathy or "seronegative" catastrophic antiphospholipid syndrome? A diagnostic dilemma. Clinical Rheumatology 26(10): 1737-1740, 2007

A case of probable catastrophic antiphospholipid syndrome with multi-organ failure presenting as a transient increase of antiphospholipid antibody levels. Nihon Rinsho Men'eki Gakkai Kaishi 37(3): 183-188, 2014

Primary antiphospholipid syndrome presenting as thrombotic microangiopathy: Successful treatment with steroids, plasma exchange and anticoagulants. Indian Journal of Nephrology 21(4): 280-282, 2011

Renal thrombotic microangiopathy and antiphospholipid syndrome nephropathy in a patient with lupus nephritis. Nihon Jinzo Gakkai Shi 58(1): 45-54, 2016

A case of primary antiphospholipid antibody syndrome with acute renal failure showing thrombotic microangiopathy. American Journal of Nephrology 19(5): 594-598, 1999

Catastrophic cerebral antiphospholipid syndrome presenting as cerebral infarction with haemorrhagic transformation after sudden withdrawal of warfarin in a patient with primary antiphospholipid syndrome. Bmj Case Reports 2010:, 2010

Overt congestive heart failure with mitral and aortic regurgitation due to antiphospholipid syndrome in a patient with systemic lupus erythematosus. Internal Medicine 39(6): 506-511, 2000

Catastrophic antiphospholipid syndrome presenting with multiorgan failure and gangrenous lesions of the skin. Angiology 59(4): 517-518, 2008

Renal thrombotic microangiopathy in a patient with rheumatoid arthritis and antiphospholipid syndrome: successful treatment with cyclophosphamide pulse therapy and anticoagulant. Internal Medicine 33(8): 484-487, 1994

Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome. Transfusion and Apheresis Science 56(3): 400-403, 2017